baber/WOPTO huggingface dataset:
Patent DE-69311295-T2 (DE)
Inventor: TUBA ZOLTAN
IPC: C07J71/00
Filed: 1993-10-29
Granted: 1997-10-30
Abstract: There is disclosed novel, therapeutically active androstane derivatives having neuromuscular blocking effect, which are substituted by a quaternary ammonium group in 16-position; pharmaceutically composition containing them; process for producing them; and novel intermediates for the production.
Patent DE-69315020-T2 (DE)
Inventor: HORROBIN DAVID FREDERICK
IPC: A61K31/20
Filed: 1993-08-16
Granted: 1998-04-16
Abstract: Increasing gut calcium absorption in humans or animals by the administration of GLA, DGLA or LA as such or in salt or other pharmacologically acceptable form, optionally in association with EPA, DHA or other EFA in similar forms, specifically useful in the treatment of osteoporosis.
Patent DE-69315788-T2 (DE)
Inventor: JACQUARD BERNARD
IPC: G05B19/4093
Filed: 1993-09-23
Granted: 1998-07-02
Abstract: The subject of the invention is improvements to a tool turret with programmable tool displacement. The tool turret of the invention is characterised in that it comprises computer-program type means for generating, with the ISO language, stored movements, the said movements being those effected by the tool during a series of operations carried out on a rough with a view to their reproduction on another rough, a keyboard for numerical control and the computer means for the numerical control: a series of machining operations having been carried out and stored in the form of a machining program, this program can be interpreted by the means for numerical control without the program having to be undertaken again. <IMAGE>
Patent DE-69317234-T2 (DE)
Inventor: CAZAUX YVON
IPC: G11C19/28
Filed: 1993-12-17
Granted: 1998-06-25
Abstract: The invention relates to charge-coupled shift registers. These registers are terminated by a read-out device, or charge/voltage conversion device, which generally includes a diode (D), a precharge transistor, (D, Gc, D') and an amplifier (A) with high input impedance. In order to enhance the efficiency of the charge transfer and, more generally, the behaviour of the register, above all at high frequencies, the invention proposes shaping the last gate (Gs) of the register, and the diode (D) in such a way that the width over which the gate is adjacent to the diode, or, put another way, the width over which the end of the charge circulation channel is adjacent to the diode, is large, while keeping a small diode surface. <IMAGE>
Patent DE-69330926-T2 (DE)
Inventor: GIDDA JASWANT SINGH
IPC: A61P1/12
Filed: 1993-07-16
Granted: 2002-04-11
Abstract: Provided is a method of treating Irritable Bowel Syndrome (IBS) using a series of isoxazole derivatives that have both 5-HT1A agonist and M1 muscarinic activities, and formulations suitable therefor.
Patent DE-69331102-T2 (DE)
Inventor: SZCZEPANSKI C
IPC: B29C57/00
Filed: 1993-08-19
Granted: 2002-08-22
Abstract: A depth filter formed of a plurality of substantially continuous intertwined filaments including a central support zone formed of support filaments having a first diameter and a filter zone formed of filtration filaments having filaments of a second diameter in which the diameters are different or the filaments are constructed of different materials. The invention also relates to an apparatus and a method for making such a depth filter element.
Patent DE-69333345-T2 (DE)
Inventor: SUTTON ANDREW DEREK
IPC: A61K49/00
Filed: 1993-10-08
Granted: 2004-10-07
Abstract: Microspheres are prepared by a process comprising the steps of (i) spray-drying a solution or dispersion of a wall-forming material in order to obtain intermediate microspheres and (ii) reducing the water-solubility of at least the outside of the intermediate microspheres. Suitable wall-forming materials include proteins such as albumin and gelatin. The microsphere have walls of 40-500 nm thick and are useful in ultrasonic imaging. The control of median size, size distribution and degree of insolubilisation and cross-linking of the wall-forming material allows novel microsphere preparations to be produced. In particular, the microspheres may be 15-20  mu m, targeted to selected areas of the body or of prolonged life in the circulation. <IMAGE>
Patent DE-69400382-T2 (DE)
Inventor: OGATA KAZUMI
IPC: A61K31/665
Filed: 1994-03-27
Granted: 1996-12-19
Abstract: This invention relates to a lipid metabolism improving medicinal composition containing a phosphoric acid diester compound of the formula or a pharmacologically acceptable salt thereof. <CHEM> wherein R1 and R2 are the same or different and each represents a hydrogen atom or a methyl group.
Patent DE-69402101-T2 (DE)
Inventor: COPPIN OLIVIER
IPC: F16H59/02
Filed: 1994-04-28
Granted: 1997-10-02
Abstract: The present invention relates to a device forming a gear-change control. The device is characterised in that the gear lever (8) is pushed transversely by an elastic means (9) bringing it automatically, when the lever (8) is placed in the longitudinal "drive" (D) position into an offset position from which longitudinal impulses on the lever change the automatic nature of the operation of the gearbox. The invention finds an application for the automatic gearboxes of motor vehicles. <IMAGE>
Patent DE-69406122-T2 (DE)
Inventor: NORA ANDREA
IPC: B01J2/16
Filed: 1994-04-19
Granted: 1998-04-09
Abstract: PCT No. PCT/EP94/01219 Sec. 371 Date Oct. 17, 1995 Sec. 102(e) Date Oct. 17, 1995 PCT Filed Apr. 19, 1994 PCT Pub. No. WO94/23831 PCT Pub. Date Oct. 27, 1994The plant for treating powders or granules enables a considerable simplification of the operation of cleaning the filters, and a more efficient centering of the basket container, and includes a tubular casing coupled in a detachable manner to a cover and a base structure. The tubular casing may be rotatable around a horizontal axis on opposing aligned appendages, and the base structure may include a basket resting on a trolley which can be lifted in a guided manner to couple with the bottom edge of the casing. The plant may be used in a wide variety of industrial applications, in particular in the chemical, food and pharmaceutical industries.
Patent DE-69415624-T2 (DE)
Inventor: MATTENET JEAN-CLAUDE
IPC: H03H7/48
Filed: 1994-10-05
Granted: 1999-05-20
Abstract: Device for distributing fast analogue signals to several users, characterised in that it comprises:   - a card of the "backplane" (F) type, on which is printed, in the form of a track, at least one two-wire distribution line (D1...DN) one end of which is fed by a source (S1...SN) of the signal to be distributed, and the other end of which is terminated on a load impedance (Zc) equal to the characteristic impedance of the line; - connection sockets (E1...EP) for printed cards, fixed onto the backplane card (F) and distributed along the distribution line (D1...DN); and - user printed cards (C1...CP) each equipped with a connector (Q) able to plug into one of the sockets (E1...EP) of the backplane printed card (F), each of these user cards (C1...CP) including an amplifier (A) the high-impedance input of which is linked to the distribution line (D1...DN) via its connector (Q) and the corresponding socket (E1...EP), and the low-impedance output of which is linked to a connection terminal (BS) for a user (U1...UP).   <IMAGE>
Patent DE-69419771-T2 (DE)
Inventor: NIEMINEN JORMA
IPC: B27N3/14
Filed: 1994-09-09
Granted: 2000-04-06
Abstract: In a method for making a fibrous product from separate particles, an air flow (A) is used for forming a mat on an advancing forming platform (1). The particles are bonded to form the mat by means of thermally activatable binder material brought to the mat forming site such that it upon being activated through the action of heat bonds the particles to each other in the mat. Said binder material is brought to an activated state already in air flow (A) carrying the particles onto forming platform (1) by setting temperature of the air flow sufficiently high. The material forming the base of the mat in the particles is constituted of a material activatable at a higher temperature than the thermally activatable binder material.
Patent DE-69420277-T2 (DE)
Inventor: DUFOUR RENEAU
IPC: F04D7/02
Filed: 1994-09-23
Granted: 2000-05-11
Abstract: Disclosed is a centrifugal liquid pump, preferably of the rotary disc type, which incorporates a gas injection assembly of very simple yet efficient structure, whereby up to 15% per volume of a gas such as air, may be mixed with the pumped liquid. The gas injection is achieved with a gas feed pipe that enters the pump through its axial inlet and with a plurality of gas injector pipes that projects from the gas feed pipe radially within the impeller.
Patent DE-69432897-T2 (DE)
Inventor: OKU YUICHI
IPC: C12Q1/68
Filed: 1994-04-28
Granted: 2004-05-27
Abstract: An assay reagent and a kit whereby nonspecific capture of a labeled substance by a solid phase can be suppressed and more than one antibody or more than one antigen can be detected via a simple assay by using one reagent. An immunological ligand assay reagent comprising components selected from the following groups (A) and (B) at the same time is reacted with immunogical ligands to thereby form complexes, which are captured by separate solid phases (C) and analyzed based on the labeling substance contained in each complex: group (A): more than one type of immunological antiligand-nucleotide conjugates wherein antibodies having specific avidities respectively for immunological ligands of different types are bonded to nucleotides which are specific respectively for said immunological ligands and each has an arbitrarily selected base sequence; group (B): labeled substances having specific avidities respectively for the immunological antiligands of different types which are to be assayed; and group (C): solid phase-nucleotide conjugates wherein nucleotides having base sequences capable of complementarily binding respectively to the nucleotides of the group (A) are bonded to a water-insoluble carrier. Either antigens or antibodies are applicable to said immunological ligands and immunological antiligands. <MATH>
Patent DE-69525348-T2 (DE)
Inventor: OHSAWA NAKAAKI
IPC: A61K31/565
Filed: 1995-08-07
Granted: 2002-09-26
Abstract: A remedy for myotonic dystrophy, containing dehydroepiandrosterone sulfate or a pharmacologically acceptable salt thereof, being efficacious for myotonia, adynamia and amyotrophy, and having a high safety.
Patent DE-69530194-T2 (DE)
Inventor: THOMPSON MARK
IPC: A01N63/50
Filed: 1995-05-05
Granted: 2003-11-13
Abstract: Bacillus thuringiensis endotoxin expression in Pseudomonads can be improved by modifying the gene encoding the Bacillus thuringiensis endotoxin. Chimeric genes are created by replacing the segment of the Bacillus thuringiensis gene encoding a native protoxin with a segment encoding a different protoxin. Exemplified herein is the cryIF/cryI(b) chimera wherein the native cryIF protoxin segment has been substituted by the cryIA(b) protoxin segment, to yield improved expression of the cryIF toxin in Pseudomonads. The invention also concerns novel genes and plasmids.
Patent DE-69531190-T2 (DE)
Inventor: GERALD P
IPC: C12Q1/68
Filed: 1995-12-01
Granted: 2004-04-15
Abstract: This invention provides the use of a chemical compound (the compound JCF 105 (SYNAPTIC 28) is exemplified) for the preparation of pharmaceutical compositions for treating abnormalities associated with the activity of a human Y5 receptor.
Patent DE-69533159-T2 (DE)
Inventor: WILDING PETER
IPC: C12Q1/68
Filed: 1995-11-13
Granted: 2005-07-21
Abstract: A mesoscale sample preparation device capable of providing microvolume test samples, separated into a cell-enriched fraction and a fraction of reduced cell content, for performing various analyses, such as binding assays, determinations involving polynucleotide amplification and the like. Analytical systems including such devices are also disclosed.
Patent DE-69601860-T2 (DE)
Inventor: BLANCHARD GILBERT
IPC: B01J23/34
Filed: 1996-01-10
Granted: 1999-10-21
Abstract: PCT No. PCT/FR96/00039 Sec. 371 Date Sep. 9, 1997 Sec. 102(e) Date Sep. 9, 1997 PCT Filed Jan. 10, 1996 PCT Pub. No. WO96/21506 PCT Pub. Date Jul. 18, 1996The invention provides a catalytic composition which is based on a cerium oxide and on at least one other oxide chosen from iron, manganese and praseodymium oxides, which controls H2S emissions in the catalysis of treatment of automobile exhaust gas.
Patent DE-69611143-T2 (DE)
Inventor: MAGNANI FRANCO
IPC: B60C25/138
Filed: 1996-09-16
Granted: 2001-04-05
Abstract: A burst protection device for tire removing machines of the type having a platform (24) on which a wheel (6) can be located and an arm (19) supporting a bead extractor (16), the burst protection device comprising a wheel locking member (1) for centering and fixing a wheel (6) on the platform (24) and a clearance signal-producing device (7) which is actuatable upon fixing of the wheel (6) on the platform (24) through the locking member (1); the signal-producing device (7) controls operation of the machine in only an active intervention stage of the wheel locking member (1). <IMAGE>
Patent DE-69622038-T2 (DE)
Inventor: URTTI OLAVI
IPC: A61K9/22
Filed: 1996-04-29
Granted: 2003-02-13
Abstract: The present invention is related to a composition for pH dependent or pH regulated controlled release of active ingredients especially drugs. The composition consists of a compactible mixture of the active ingredient and starch molecules substituted with acetate and dicarboxylate residues. The preferred dicarboxylate acid is succinate. The average substitution degree of the acetate residue is at least 1 and 0.2-1.2 for the dicarboxylate residue. The starch molecules can have the acetate and dicarboxylate residues attached to the same starch molecule backbone or attached to separate starch molecule backbones. The present invention also discloses methods for preparing said starch acetate dicarboxylates by transesterification or mixing of starch acetates and starch dicarboxylates respectively.
Patent DE-69709780-T2 (DE)
Inventor: MCLEAN GAIL
IPC: C10L10/04
Filed: 1997-09-11
Granted: 2002-05-29
Abstract: An additive concentrate for use in fuels, especially in gasoline for internal combustion engines, comprising (a) 0.2 to 10 wt.% ashless friction modifier which is liquid at room temperature and pressure selected from (i) n-butylamine oleate or derivatives thereof, (ii) a substance comprising tall oil fatty acid or derivatives thereof, and (iii) mixtures of (i) and (ii); (b) 10 to 80 wt.% deposit inhibitor, and (iii) carrier fluid. The particular selection of friction modifier (a) enables a stable additive concentrate to be formulated without the need for additional solubilising agent for the friction modifier, whilst containing sufficient friction modifier to achieve a significant benefit in friction loss, when incorporated in gasoline used to fuel an internal combustion engine, and hence an improvement in fuel economy.
Patent DE-69723966-T2 (DE)
Inventor: VOGEL THOMAS
IPC: C09D163/00
Filed: 1997-02-28
Granted: 2004-07-22
Abstract: A curable composition is described, comprising a) 10 to 90% by weight of at least one, optionally water-dilutable, water-emulsifiable or water-dispersible, epoxy resin having more than one epoxy group in the molecule; b) 90 to 10% by weight of at least one polyamine adduct which predominantly corresponds to the idealised formula (I) and which is prepared from an adduct of formula (A) and a polyamine of formula (XII), wherein the sum of the percentages by weight of components (a) and (b) is always 100%; c) optionally, at least one further aliphatic, cycloaliphatic, aromatic/aliphatic, aromatic or heteroaromatic mono- or polyamine which may optionally be modified by adduction; and d) optionally, at least one customary additive, R1 and R2 and also m and n and B being defined in more detail in the description. The novel compositions are used for the preparation of colourants and coatings.
Patent DE-69731968-T2 (DE)
Inventor: ARTMAN D
IPC: A61P25/06
Filed: 1997-08-29
Granted: 2005-12-22
Abstract: Preparations and extracts of valerian, as well as isovaleramide, isovaleric acid, and its pharmaceutically acceptable salts, esters, and substituted amides, exhibit clinically significant pharmacological properties which implicate a treatment for a variety of pathological conditions, including spasticity and convulsions, which are ameliorated by effecting a mild depression of CNS activity. The compositions in question generally are non-cytotoxic and do not elicit weakness or sedative activity at doses that are effective for the symptomatic treatment of such pathological conditions.
Patent DE-69818014-T2 (DE)
Inventor: ANSLIN JYRKI
IPC: A61G7/10
Filed: 1998-02-18
Granted: 2004-07-08
Abstract: A support device provided to be arranged on a base member (1) such as a mattress, a bunk or a bed, and comprising an inflatable portion (2) which is arranged to be in an inflated state in order to lift a person resting upon the inflatable portion (2), the inflatable portion (2) comprising an inlet opening (5) and an outlet opening (6) for the supply and evacuation respectively of an inflation medium. The inflatable portion (2) comprises a lateral projection (4) provided to project beyond a lateral edge (3) of the base member (1) and at which the inlet opening (5) and the outlet opening (6) are arranged.
Patent DE-69836597-T2 (DE)
Inventor: CUMMING J STUART
IPC: A61F2/16
Filed: 1998-12-09
Granted: 2007-10-11
Abstract: The invention is directed to an accommodating intraocular lens to be implanted in a human eye (10) within a capsular bag (20) in the eye having a posterior capsule (24) and an anterior capsule remnant (22) bounded by an anterior capsular remnant, a lens (32) comprising a flexible lens body (33) having normally anterior and posterior sides and including an optic (34) and haptics (36) having inner ends joined to diametrically opposite sides of the optic and having opposite outer ends the lens body being moveable anteriorly by ciliary muscle constriction along the axis of the eye. <IMAGE>
Patent DE-69836968-T2 (DE)
Inventor: KHUDYAKOV E
IPC: G01N33/576
Filed: 1998-08-21
Granted: 2007-10-31
Abstract: A mosaic protein comprising a variety of immunoreactive antigenic epitopes from several genotypes of hepatitis C virus. The mosaic protein provides a sensitive and specific immunological hepatitis detection assay. A restriction enzyme assisted ligation method of making an artificial gene permits controlled construction of mosaic proteins, and allows confirmatory expression of the intermediate gene products.
Patent DE-69836986-T2 (DE)
Inventor: CHEN YUGUANG
IPC: A01N47/02
Filed: 1998-12-14
Granted: 2007-11-15
Abstract: The pesticide to be used without causing phytotoxicity to the seed. Insecticidal coating for a corn seed comprises: (1) one or more binders comprising polymers or copolymers of polyvinylacetate, methyl cellulose, polyvinyl alcohol, vinylidene chloride, acrylic, cellulose, polyvinylpyrrolidone or polysaccharide; (2) an insecticidal heterocycle of formula (I) or its tautomer or salt, optionally in combination with imidacloprid or its analogues, organophosphate, phenyl pyrazole and/or a pyrethroid: and (3) one or more fillers, where the binder forms a matrix for the insecticide and filler on the corn seed and the filler is present in an amount to prevent or reduce the phytotoxic effect on the corn seed caused by the insecticide. The coated seed is claimed per se. [Image] A : optionally mono- to tetrasubstituted, optionally aromatic, mono- or bicyclic heterocycle, where 1-2 of the substituents are Q aand 1-4 of the substituents are Q b; Q a1-3C haloalkyl, cyclopropyl, halocyclopropyl, 2-3C alkenyl, 2-3C alkynyl, 2-3C haloalkenyl, 2-3C haloalkynyl, 1-3C haloalkoxy, 1-3C alkylthio, 1-3C haloalkylthio, allyloxy, propargyloxy, allylthio, propargylthio, haloallyloxy, haloallylthio, CN or NO 2; Q b1-3C alkyl, 1-3C alkoxy or halogen; R = H, 1-6C alkyl, phenyl-1-4C alkyl, 3-6C cycloalkyl, 2-6C alkenyl or 2-6C alkynyl; and X : N-NO 2or N-CN. Independent claims are included for the following: (1) control of insect pests from damaging a corn plant comprising applying the above coating to a corn seed; (2) preparation of coated corn seeds; and (iii) a method of protecting emerging seedlings of a crop plant form one or more insect organisms in the seed growing soil environment comprising applying the above coating to he seeds. ACTIVITY : Insecticide;.
Patent DE-69838647-T2 (DE)
Inventor: NG FRANK MAN-WOON
IPC: A61P43/00
Filed: 1998-09-04
Granted: 2008-08-28
Abstract: A method for the treatment of obesity in an animal such as a human, comprises administering to the animal an effective amount of a peptide which comprises an analogue of the carboxyl-terminal sequence of a growth hormone, particularly an analogue of the carboxyl-terminal sequence of human growth hormone containing amino acid residues 177-191. A pharmaceutical composition for use in the treatment of obesity is also disclosed.
Patent DE-69903449-T2 (DE)
Inventor: TAGHAVI-KHANGHAH SAID
IPC: B65D47/32
Filed: 1999-07-30
Granted: 2003-06-18
Abstract: A container for dispensing liquids includes a body member and a closure therefor. The closure includes a cap in the form of a plastic moulding having an outlet and a control valve within the cap. The control valve is a one piece plastic moulding having a diaphragm portion and a nose portion. The nose portion normally seals the outlet but is displaceable therefrom on distortion of the diaphragm portion resulting from pressurization of the interior of the body member and whereby liquid is dispensed through the outlet. The cap further includes an annular seating for the control valve which is of hollow, open-ended, generally cylindrical shape, the diameter of which is on the same order to that of the diaphragm portion of the control valve.
Patent DE-69903732-T2 (DE)
Inventor: BURGER HENRI TTE
IPC: A61L27/12
Filed: 1999-07-02
Granted: 2003-07-03
Abstract: The invention relates to bone material for the prevention and treatment of osteomyelitis, which material is provided with antimicrobial peptides (AMPs) consisting of an amino acid chain which contains a domain of 10 to 25 amino acids, wherein the majority of the amino acids of the one half of the domain are positively charged amino acids and the majority of the amino acids of the other half of the domain are uncharged amino acids, which AMPs can be released to the surrounding area for a period of time and wherein the bone material forms bone cement after curing and the AMPs are distributed homogeneously in the cured bone cement. The invention further relates to a method of manufacturing the bone material, wherein the bone material is cured to bone cement and wherein the AMPs are distributed homogeneously in the cured bone cement.
Patent DE-69904059-T2 (DE)
Inventor: DURAND CLAUDE
IPC: B01J8/00
Filed: 1999-08-10
Granted: 2003-05-08
Abstract: A continuous process for gas phase coating of polymerization catalyst. The polymerization catalyst is introduced in a gas phase plug flow type reactor wherein it is submitted to polymerization conditions in the presence of at least one monomer such that at least 95% by weight of the produced coated catalysts have a coating yield comprised between 0.5 to 2 times the average coating yield.